In the last trading session, 9.12 million Bristol-Myers Squibb Co. (NYSE:BMY) shares changed hands as the company’s beta touched 0.45. With the company’s per share price at $43.90 changed hands at -$0.09 or -0.20% during last session, the market valuation stood at $88.99B. BMY’s last price was a discount, traded about -57.4% off its 52-week high of $69.10. The share price had its 52-week low at $43.33, which suggests the last value was 1.3% up since then. When we look at Bristol-Myers Squibb Co.’s average trading volume, we note the 3-month average coming to 15.85 million.
Bristol-Myers Squibb Co. (NYSE:BMY) trade information
Instantly BMY was in red as seen at the end of in last trading. With action -1.66%, the performance over the past five days has been red. The drop to weekly highs of 44.76 subtracted -0.20% to the stock’s daily price. The company’s shares are showing year-to-date downside of -14.44%, with the 5-day performance at -1.66% in the red. However, in the 30-day time frame, Bristol-Myers Squibb Co. (NYSE:BMY) is -14.46% down.
Bristol-Myers Squibb Co. (BMY) estimates and forecasts
Data shows that the Bristol-Myers Squibb Co. share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -14.14% over the past 6 months, a -92.14% in annual growth rate that is considerably lower than the industry average of 13.00%. Year-over-year growth is forecast to reach 1.70% up from the last financial year.
Consensus estimates given by 16 financial analysts project the company’s revenue in the current quarter to hit an average of 10.69B. 15 analysts are of the opinion that Bristol-Myers Squibb Co.’s revenue for the current quarter will be 10.39B. The estimates for the next quarter sales put growth at 4.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 5.14%. The 2024 estimates are for Bristol-Myers Squibb Co. earnings to decrease by -92.88%, but the outlook for the next 5-year period is at -4.45% per year.
BMY Dividends
Bristol-Myers Squibb Co. is expected to release its next quarterly earnings report in June. The 5.33% annual yield figure for the share gives it an annual dividend of 2.34. It is important to note, however, that the 5.33% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.
